Success Metrics

Active Trials
7(100%)

Phase Distribution

Ph phase_3
1
14%
Ph phase_1
1
14%
Ph phase_2
5
71%

Phase Distribution

1

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
5(71.4%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

7

all time

Status Distribution
Active(7)

Detailed Status

Recruiting7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
7
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 25 (71.4%)
Phase 31 (14.3%)

Trials by Status

recruiting7100%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7